277 related articles for article (PubMed ID: 26448174)
21. Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome.
Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S
Br J Ophthalmol; 2008 Jul; 92(7):989-91. PubMed ID: 18577653
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome.
Ueta M; Sotozono C; Inatomi T; Kojima K; Tashiro K; Hamuro J; Kinoshita S
Br J Ophthalmol; 2007 Jul; 91(7):962-5. PubMed ID: 17314152
[TBL] [Abstract][Full Text] [Related]
23. HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens-Johnson syndrome with severe ocular complications.
Ueta M; Tokunaga K; Sotozono C; Sawai H; Yoon KC; Kum Kim M; Yul Seo K; Joo CK; Tashiro K; Kinoshita S
Hum Genome Var; 2015; 2():15023. PubMed ID: 27081535
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Ocular Manifestation and Genetic Association of Allopurinol-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in South Korea.
Lee HS; Ueta M; Kim MK; Seo KY; Sotozono C; Kinoshita S; Yoon KC
Cornea; 2016 Feb; 35(2):199-204. PubMed ID: 26655481
[TBL] [Abstract][Full Text] [Related]
25. Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement.
Ueta M; Kaniwa N; Sotozono C; Tokunaga K; Saito Y; Sawai H; Miyadera H; Sugiyama E; Maekawa K; Nakamura R; Nagato M; Aihara M; Matsunaga K; Takahashi Y; Furuya H; Muramatsu M; Ikezawa Z; Kinoshita S
Sci Rep; 2014 Apr; 4():4862. PubMed ID: 24781922
[TBL] [Abstract][Full Text] [Related]
26. HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese.
Ueta M; Tokunaga K; Sotozono C; Inatomi T; Yabe T; Matsushita M; Mitsuishi Y; Kinoshita S
Mol Vis; 2008 Mar; 14():550-5. PubMed ID: 18385790
[TBL] [Abstract][Full Text] [Related]
27. Human leukocyte antigen B*0702 is protective against ocular Stevens-Johnson syndrome/toxic epidermal necrolysis in the UK population.
Butt GF; Hassan A; Wallace GR; Kinoshita S; Ahmad S; Ueta M; Rauz S
Sci Rep; 2021 Feb; 11(1):2928. PubMed ID: 33536518
[TBL] [Abstract][Full Text] [Related]
28. Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Saito K; Ueta M; Maekawa K; Sotozono C; Kinoshita S; Saito Y
PLoS One; 2016; 11(11):e0167402. PubMed ID: 27898730
[TBL] [Abstract][Full Text] [Related]
29. Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study.
Ueta M; Sotozono C; Nakano M; Taniguchi T; Yagi T; Tokuda Y; Fuwa M; Inatomi T; Yokoi N; Tashiro K; Kinoshita S
J Allergy Clin Immunol; 2010 Dec; 126(6):1218-25.e10. PubMed ID: 20947153
[TBL] [Abstract][Full Text] [Related]
30. Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens-Johnson syndrome with severe ocular complications in Japanese individuals.
Ueta M; Nakamura R; Saito Y; Tokunaga K; Sotozono C; Yabe T; Aihara M; Matsunaga K; Kinoshita S
Hum Genome Var; 2019; 6():50. PubMed ID: 31666976
[TBL] [Abstract][Full Text] [Related]
31. Clinical Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Severe Ocular Complications in South Korea.
Kim MK; Yoon KC; Yoon SH; Seo KY
Front Med (Lausanne); 2021; 8():640360. PubMed ID: 33693020
[TBL] [Abstract][Full Text] [Related]
32. Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population.
Kannabiran C; Ueta M; Sangwan V; Rathi V; Basu S; Tokunaga K; Kinoshita S
Sci Rep; 2017 Nov; 7(1):15960. PubMed ID: 29162886
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
Chung WH; Hung SI
J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
[TBL] [Abstract][Full Text] [Related]
34. Clinical Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Severe Ocular Complications in Brazil.
Wakamatsu TH; Dos Santos MS; Barreiro TP; Sant'Anna AEBPP; Murta F; da Costa AX; Marculino LGC; de Alcântara RJA; de Farias CC; Gomes JÁP
Front Med (Lausanne); 2021; 8():649369. PubMed ID: 34222274
[TBL] [Abstract][Full Text] [Related]
35. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
36. Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy.
Chang VS; Chodosh J; Papaliodis GN
Semin Ophthalmol; 2016; 31(1-2):178-87. PubMed ID: 26959145
[TBL] [Abstract][Full Text] [Related]
37. [HLA-class I gene polymorphisms in Japanese Stevens-Johnson syndrome patients with ocular surface complications].
Nakaji S; Ueta M; Sotozono C; Inatomi T; Kinoshita S
Nippon Ganka Gakkai Zasshi; 2012 Jun; 116(6):581-7. PubMed ID: 22774598
[TBL] [Abstract][Full Text] [Related]
38. Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Sotozono C; Ueta M; Nakatani E; Kitami A; Watanabe H; Sueki H; Iijima M; Aihara M; Ikezawa Z; Aihara Y; Kano Y; Shiohara T; Tohyama M; Shirakata Y; Kaneda H; Fukushima M; Kinoshita S; Hashimoto K;
Am J Ophthalmol; 2015 Aug; 160(2):228-237.e2. PubMed ID: 25979679
[TBL] [Abstract][Full Text] [Related]
39. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI
Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
[TBL] [Abstract][Full Text] [Related]
40. Severe Dry Eye With Combined Mechanisms is Involved in the Ocular Sequelae of SJS/TEN at the Chronic Stage.
Sotozono C; Ueta M; Yokoi N
Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES80-DES86. PubMed ID: 30481810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
